Showing results (241-250 of 944) with videos related to
Sort By:
Pageof 95
CNS Drugs|June 28, 2003
The glutamatergic system and Alzheimer's disease: therapeutic implicationsD Allan Butterfield, Chava B PocernichPhilosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|March 11, 2003
The GAMBLE project: a fresh approach to satellite remote sensing of the seaT D Allan, E R Ash, Cell|July 30, 2008
Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolutionD Allan Drummond, Claus O WilkeNature Reviews. Genetics|September 19, 2009
The evolutionary consequences of erroneous protein synthesisD Allan Drummond, Claus O WilkeJournal of Applied Clinical Medical Physics|September 11, 2014
Method for verifying the air kerma strength of I-125 plaques for the treatment of ocular melanomaL W Zimmermann, D Allan WilkinsonJournal of Neurochemistry|September 15, 2018
Redox proteomics and amyloid β-peptide: insights into Alzheimer diseaseD Allan Butterfield, Debra Boyd-KimballThe Biochemical Journal|December 15, 1996
ADP-ribosylation factor 1-regulated phospholipase D activity is localized at the plasma membrane and intracellular organelles in HL60 cellsJ Whatmore, C P Morgan, E Cunningham, et al.European Journal of Pharmacology|July 25, 2006
Oxidative stress in Alzheimer's disease brain: new insights from redox proteomicsD Allan Butterfield, Marzia Perluigi, Rukhsana SultanaThe Biochemical Journal|June 15, 1980
The isolation and characterization of 60 nm vesicles ('nanovesicles') produced during ionophore A23187-induced budding of human erythrocytesD Allan, P Thomas, A R LimbrickBiochimica Et Biophysica Acta|February 24, 1993
Monensin inhibits synthesis of plasma membrane sphingomyelin by blocking transport of ceramide through the Golgi: evidence for two sites of sphingomyelin synthesis in BHK cellsK J Kallen, P Quinn, D AllanPageof 95